104 results
Page 3 of 6
8-K
EX-99.1
xma9l zxtyigb
6 Oct 22
Nurix Therapeutics Reports Third Quarter Fiscal 2022 Financial Results and Provides a Corporate Update
4:10pm
8-K
EX-99.1
rs76m9maikyq d9y
14 Sep 22
Nurix Therapeutics Appoints Leading Industry Strategist Edward C. Saltzman to its Board of Directors
4:01pm
8-K
EX-99.1
oi7p18wjmsep1p
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
EX-10.1
vtu7ak
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
EX-99.2
f7yofccuyqd8ty bz
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
424B5
kojr64
8 Jul 22
Prospectus supplement for primary offering
4:10pm
424B5
nfni57pmb xtubkrpv
8 Jul 22
Prospectus supplement for primary offering
4:09pm
8-K
EX-99.1
usjbp6
7 Jul 22
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update
4:09pm
8-K
EX-99.2
38bsgqa grgsu8k4zs
26 May 22
Other Events
7:02am
8-K
EX-99.1
zzf4 94lhxb
26 May 22
Other Events
7:02am
8-K
EX-99.1
16odbtff0 76rc6bzot
7 Apr 22
Nurix Therapeutics Reports Fiscal First Quarter 2022 Financial Results and Provides a Corporate Update
4:08pm